Inform2 Exploratory Multinational Phase I/Ii Combination Study Of Nivolumab And Entinostat In Children And Adolescents With Refractory High-Risk Malignancies: Inform2 Nivent.

JOURNAL OF CLINICAL ONCOLOGY(2019)

引用 5|浏览43
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要